Similimum, Drug Proving, Similia Similibus Curentur, Homeopathic Cure – Science in a Nutshell
If a drug substance could produce some groups of symptoms that are similar to those expressed in a disease condition, what does it mean?
It means the drug substance and disease-causing subatance could produce similar errors in siimilar biochemical pathways in the organism.
It means, the drug substance contained some chemical molecules having functional groups similar to those contained in disease causing substance, so that they could bind to similar biomolecular targets in the organism and produce similar molecular inhibitions.
In the language of modern biochemistry, it could be said that the chemical molecules in disease causing substance and the chemical molecules contained in the drug substance have a COMPETITIVE RELATIONSHIP, and they compete each other in binding to similar biological targets.
Both of them will have a COMPETITIVE relationship also with the natural ligands of those biological target molecules.
This phenomenon of COMPETITIVE RELATIONSHIP in biochemical interactions play a big role in molecular processes involved in DISEASE processes, DRUG toxicity as well as CURE.
Modern drug designing techniques are based on the study of this phenomenon of COMPETITIVE RELATIONSHIP.
What HOMEOPATHY calls SIMILIMUM is actually a drug substance that contains some chemical molecules that can COMPETITIVE with the disease causing molecules.
Since molecular inhibitions are expressed through SYMPTOMS, homeopathy identifies this relationship by observing the SIMILARITY OF SYMPTOMS produced in human body by DISEASE as well as those produced by what is called DRUG PROVING.
When drugs are potentized, the individual chemical molecules contained in the the drug substance undergo a peculiar supra-molecular process known as MOLECULAR IMPRINTING in modern polymer chemistry.
Through host-guest interactions between water-alcohol supra-molecular matrix and individual drug molecules, three dimensional nanocavities are formed, having conformations just complementary to the drug molecules that work as templates in this process.
These nanocavities are called MOLECULAR IMPRINTS. These molecular imprints can act as ARTIFICIAL BINDING POCKETS for disease causing molecules having complementary RELATIONSHIP.
As such, molecular imprints can bind to and deactivate the disease causing molecules, thereby removing molecular inhibitions of biological molecules. This is CURE.
It is obvious that molecular imprints of similar molecules will have complementary affinity towards all chemical molecules having similar functional groups, or which have COMPETITIVE RELATIONSHIP to each other.
SIMILIMUM, DRUG PROVING and SIMILIA SIMILIBUS CURENTUR are explained above very clearly, in a way fitting to modern scientific knowledge system.
I am not responsible if you could not understand, or if you hesitate to understand!
- Posted in: Uncategorized